Schedule 13D ownership disclosure

DelMar Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 247078108

Event date: 2014-08-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
17.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013762-14-001085
Form type
SC 13D/A
Filer
BACHA JEFFREY
CIK
CIK 1432149
Filed
Sep 17, 2014
Reporting period
Aug 21, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub